Division of Cardiology, Yonsei University College of Medicine, Severance Cardiovascular Hospital, Yonsei University Health System, Seoul, Korea.
Korean Circ J. 2013 Jan;43(1):66-9. doi: 10.4070/kcj.2013.43.1.66. Epub 2013 Jan 31.
An aberrant right subclavian artery (ARSA) is the most common vascular abnormality of the aortic arch and is associated with development of aneurysms in 3-8% of these anomalies. In this case report, we describe an 84-year-old man with a symptomatic ARSA treated with staged hybrid procedure combining surgical replacement of the ascending aorta and bilateral carotid-to-subclavian artery bypass with implantation of a stent graft in the aortic arch and descending aorta. Our case suggests that a less invasive hybrid therapy can be performed successfully for the treatment of ARSA with aneurysmal change in patients at high surgical risk.
异常右锁骨下动脉(ARSA)是主动脉弓最常见的血管异常,在这些异常中,有 3-8%会发展为动脉瘤。在本病例报告中,我们描述了一位 84 岁的男性患者,他患有症状性 ARSA,接受了分期杂交手术治疗,该手术结合了升主动脉置换术和双侧颈动脉-锁骨下动脉旁路术,并在主动脉弓和降主动脉中植入了支架移植物。我们的病例表明,对于高手术风险的患者,一种微创的杂交治疗方法可以成功地用于治疗伴有动脉瘤样改变的 ARSA。